Neural Plasticity
Volume 2017 (2017), Article ID 4296075, 8 pages
https://doi.org/10.1155/2017/4296075

Review Article

Therapeutic Potentials of Synapses after Traumatic Brain Injury: A Comprehensive Review

Zunjia Wen,1,2 Dong Li,³ Meifen Shen,1,2 and Gang Chen¹

¹Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, China
²School of Nursing, Medical College of Soochow University, Suzhou 215006, China
³Department of Neurosurgery, Lianyungang Hospital of Traditional Chinese Medicine, Lianyungang 222004, China

Correspondence should be addressed to Gang Chen; nju_neurosurgery@163.com

Received 29 November 2016; Revised 9 February 2017; Accepted 14 March 2017; Published 12 April 2017

Academic Editor: Chih-Lung Lin

Copyright © 2017 Zunjia Wen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Massive studies have focused on the understanding of the pathobiology of cellular and molecular changes and injury mechanisms after traumatic brain injury (TBI), but very few studies have specially discussed the role of synapses in the context of TBI. This paper specifically highlights the role and therapeutic potentials of synapses after TBI. First, we review and conclude how synapses interact with constant structural, metabolic, neuroendocrine, and inflammatory mechanisms after TBI. Second, we briefly describe several key synaptic proteins involved in neuroplasticity, which may be novel neuronal targets for specific intervention. Third, we address therapeutic interventions in association with synapses after TBI. Finally, we concisely discuss the study gaps in the synapses after TBI, in hopes that this would provide more insights for future studies. Synapses play an important role in TBI; while the understandings on the synaptic participation in the treatments and prognosis of TBI are lacking, more studies in this area are warranted.

1. Introduction

It is well established that traumatic brain injury (TBI) is closely related to the occurrences, evolvements, and prognosis of psychiatric disorders, neuronal dysfunction, and cognitive impairment [1–3]; however, the mechanisms underlying the diseases at the cellular and molecular levels such as inflammation involvement, metabolic homeostasis imbalance, and synaptic injury remain elusive. If remain untouched, it may increase the potentials for many short-term (bleeding, headaches) and long-term (cognitive impairments) symptoms [2]; therefore, the studies on the mechanisms elaborating the cellular and molecular pathology should be put on the top agenda of TBI researches.

Synapse as a basic element for brain structure has been believed to play a significant role in the disadvantageous influences following TBI; the regular fusing of the synaptic vesicle and the plasma membrane and the orderly releasing of neurotransmitters into the synaptic cleft seem to be essential to the normal neuronal interaction [4]. Although it is now widely acknowledged that synapse is important to brain development and cognitive functions [5–7], the molecular mechanisms that the synapse structure and function changes induced by TBI remain largely unclear [8–10]. Besides, the databases on synapse categories have identified 109 domains involved in synaptic functions and more than 5000 synaptic proteins [11], yet very few of the synaptic proteins have been proven to be related with the synaptic dysfunction after TBI. Comprehensive reviews on the role of synapses after TBI are significantly necessary to figure out the study status and to elucidate future studies.

TBI is a kind of disease with a lot of factors involved; the prognosis differs from one to another, and it is under the interaction of various mechanisms working unitedly or orderly, which make TBI treatment quite complicated. Therefore, we conducted this comprehensive review on the role of synapse after TBI, which mainly focused on the interactions between different functional mechanisms and synapses (Figure 1), the related synaptic proteins (Figure 2), and the targeted treatments on improving the synaptic plasticity after TBI, to provide insights into future studies in this area.

Figure 1: A brief drawing of the synaptic interaction with constant structural, metabolic, neuroendocrine, and inflammatory mechanisms after TBI; AMPAR: α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; NMDAR: N-methyl-D-aspartate receptor; Glu: glutamate.

Figure 2: A brief distribution and construction of synaptic proteins. Notes: Syt-I: synaptotagmin-I; Syt-IV: synaptotagmin-IV; Syt-IV: synaptotagmin-IV; PSD-93: postsynaptic density complex protein-93; PSD-95: postsynaptic density complex protein-95.

2. The Interactions between Functional Mechanisms and Synapses

2.1. The Interaction between Direct Structural Injury and Synapses after TBI

It is under estimation that more than 10¹¹ neurons exist in the adult human brain, and each of them is constructed with 10⁴ synapses [12]. Synaptic structures have been reported to be highly vulnerable to the direct or indirect concussion attack following TBI in experimental and clinical settings [13, 14]. The focal mechanical attack resulting from the direct or contoured violence may lead to the structurally or functionally synaptic disconnection, and the structural changes of the synaptic cleft, the presynaptic and postsynaptic densities (PSDs), may cause temporary or long-term synaptic loss. This primary damages may trigger the biophysical and neurochemical change cascades and finally give rise to either synaptic repair or eternal loss.

2.2. The Interaction between Disturbed Energy Metabolism and Synapses after TBI

Membrane depolarization is initiated instantly by the damage on neuronal membranes and axons induced by TBI [15], leading to massively excitatory neurotransmitter release such as glutamate [16, 17]. The glutamate not only results in intracellular calcium accumulation but also activates the N-methyl-D-aspartate receptor (NMDAR) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) [18, 19]. Additionally, mitochondrial dysfunction may occur due to the elevated calcium influx activating the intracellular proteases and finally lead to neuronal apoptosis. A huge body of energies are needed to maintain the metabolic and ionic homeostasis, and accordingly, the demand for blood glucose will increase, causing an imbalance between glucose supply and demand.

The synapses play a significant role in this process. Long-term potentiation (LTP) may be triggered by the activation of excitatory synapses, a process that requires intracellular calcium accumulation in the dendritic spine by activating NMDAR [20, 21]. The magnesium ions may block these receptor channels in a physiological situation with voltage-controlled method; however, in the stressing conditions induced by TBI, the cell depolarization largely by activating AMPAR may extrude the magnesium ions [22, 23]. Therefore, the NMDAR and AMPAR can significantly influence the LTP and eventually the energy metabolism.

2.3. The Interaction between Changed Neuroendocrine Secretion and Synapses after TBI

The disturbance of the hypothalamic-pituitary-adrenal (HPA) axis has been reported in several TBI studies [24–26]. The TBI may lead to increased serum cortisol and adrenocorticotropic hormone (ACTH) level to regulate other organs in this stressing condition; on one hand, those neuroendocrine hormones may alert the body to better deal with TBI, and on the other hand, the overexpression of stress hormones can significantly facilitate the TBI. However, it should be pointed out that although HPA axis changes after TBI is well documented, the direct linkages between synaptic dysfunction and HPA after TBI remain not clear, and the direct linkage of synaptic dysfunction to post-TBI HPA dysfunction needs to be further explored in future studies.

At the same time, it should be noted that the secretions of neurotrophins in the hippocampus are reduced after TBI. Neurotrophins served as “autocrine” in regulating the brain as the target organ contain many secretory proteins including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3), and so on. Close relationships have been found between neurotrophins and synapse structures and functions; the neurotrophins may influence axonal and dendritic branching and remodelling [27–29], synaptogenesis in arborizing axon terminals [30], synaptic transmission [31–33], and synapsis maturation [32, 34]. In the context of TBI, the stress hormones are excessively secreted and neurotrophin secretion decreases; accordingly, the synapses tend to be seriously damaged. How to control and adjust the neuroendocrine secretion and synapsis development after TBI is a tricking yet promising problem in the treatment of TBI.

2.4. The Interaction between Increased Inflammation Responses and Synapses after TBI

TBI-induced physiological changes may give rise to neuroinflammation and neuron death [35]. A body of proinflammatory cytokines are rapidly elevated in the acute period including IL-6, TNF-α, and so on [36]; besides, the increased cytokines levels in the brain are dramatically higher than the corresponding levels in serum [37]. Generally, the existence of proinflammatory cytokines are required for preserving synaptic strength at excitatory synapses, and it is essential to synaptic plasticity [38, 39], but excessive secretion of proinflammatory cytokines may produce detrimental effects on the synapses [40].

The TBI-induced blood-brain barrier (BBB) integrity disruption acts an important role in the neuroinflammatory response [41], which allows increased cytokine pour into the brain and ultimately activate microglia in excess. The microglia is highly alerted in the acute period after TBI [41]. The microglia offers a beneficial hand to neuronal circuit formation via phagocytosing weak synapses and regulating neurogenesis [42], but excessive microglia accumulations may cause serious impairments to the synaptic pruning and disrupt the synaptic plasticity [43, 44]. It should be emphasized that microglia might be linked to synaptic integrity in the inflammation response, yet no studies have specifically dealt with this issue in the context of TBI. The direct evidence linking microglia activation and cytokine elevation of synaptic changes after TBI is lacking, more studies on these issue are warranted.

3. The Major Synaptic Proteins Involved in TBI

Up to date, more than 5000 synaptic proteins have been identified [11], and most of them have been found in association with neurological diseases such as stroke, TBI, Alzheimer’s disease, and so on. Based on literature review, we identify several key synaptic proteins and introduce them briefly (Figure 2).

A linear polymer microfilament called F-actin, which is essential for such important cellular functions as the mobility and contraction of cells during cell division [45, 46], is considered to have structural polarity which is critical to synaptotagmins [47, 48]. Synaptotagmins family is a kind of calcium-binding protein located in the synaptic vesicles, and Syt-I and Syt-IV are the most relevant in TBI. Syt-I proteolysis may hinder the synaptic vesicle from docking to the presynaptic membrane terminal [49, 50]; besides, the accumulation of deformed Syt-I may cause disadvantageous effects on presynaptic function [51], while Syt-IV increases massively after TBI and tends to reduce synaptic activity [52]. The synapsins are a family of phosphoproteins with a function of regulating the release of neurotransmitter in the presynaptic area [53]. It has been hypothesized that increased oxidative stress after TBI may lead to synapsin-I loss and further disturb the interactions between synapses [54]. Synaptophysin is a kind of calcium-binding glycoprotein acting in vesicular trafficking, docking, synaptogenesis, and synaptic plasma membrane fusing in the presynaptic. It is noteworthy that the role of synaptophysin involved in TBI remains unclear; it is found that synaptophysin levels change differently between the mild and severe TBI [55], but another study addressing these issues remains somewhat contradictory [56]. Synaptojanins act a significant role in recycling vesicles at the presynaptic area. Synaptojanin-I is predominantly distributed in nerve terminals and is extremely sensitive to calpain digestion [57]; therefore, it has been taken as a novel target for degradomic calpain [51].

4. The Treatments Targeted on Synapses after TBI

With consideration to the important role synapses played in the TBI prognosis, lots of strategies have been adopted to enhance the synaptic plasticity and promote synaptic function, and even though the treatments may largely differ, the basic principles for speeding recovery from TBI remain similar, that is, promoting synaptogenesis and synaptic terminal reconnection and then exerting the neuroprotective effects [58].

Exercises are believed to be effective in improving TBI prognosis; the underlying mechanisms include changing the brain structural integrity by enhancing neurogenesis and angiogenesis with more secretions of growth factors promoting synaptic plasticity [59–61]. Notably, aerobic exercises such as tai chi and yoga have been popularly promoted for its potential advantages in healthy and ill-attacked populations [62–67]; however, the frequency and burden of exercise after TBI differ from one to another and remain to be further elucidated [68].

Several experiments in the animal with significant synaptic function improvement should be considered. Inhibiting endocannabinoid degradation may ameliorate the neurobehavioral, neuroinflammatory, and glutamate dyshomeostasis after TBI via reducing synaptic hyperexcitability [69]. Pycnogenol, one kind of bioflavonoid with significant antioxidant and anti-inflammatory properties, provides a beneficial effect on improving CA3-CA1 synaptic function in rats after TBI [70]. Another lab study [71] indicates that tyrosine kinase EphB3 produces deleterious effects on maintaining synaptic stability and plasticity after TBI. Resveratrol, a polyphenol compound with antioxidant properties, can upregulate synaptophysin and PSD 95 and suppress neuronal autophagy [72]. Rapamycin may exert suppressing effects on the neurogenesis and synaptic reorganization shortly after TBI in the dentate gyrus and cause a neuroprotective effect [73]. Additionally, dietary omega-3 fatty acids intake can protect against the decreased synaptic plasticity and impaired learning ability after TBI [74]. Meanwhile, the low-level laser therapy after TBI seem to increase the BDNF level and promote synaptogenesis [75]. However, these data only indicate the potential use for TBI treatments [76, 77], and more clinical evaluations are needed to assess the value of these findings.

5. Study Gaps and Future Direction

The understanding on the synaptic mechanisms involved in TBI still remains incomplete, and the interactions between synapses and the other injury mechanisms still need to be ascertained. Also, even though three-dimensional in vitro injury systems have been proposed to connect the injury degree and cell responses [78], the majority of studies are conducted in animals but not in humans, and verifying these findings in human use is a big step to move on. Particularly, the synaptic proteins in TBI are not well-studied; most studies are confined in the pathological conditions of stroke or subarachnoid hemorrhage, and more synaptic protein-related studies may facilitate the identification of new proteins and protein-targeted treatments.

Notably, the synapses seem to respond differently to the mild and severe TBI, indicating that subanalysis on the role of synapses in accordance with the degree of TBI is warranted, and based on the literature review, we found that the studies on the severe TBI were rather insufficient, regardless of molecular mechanisms or treatment options. In addition, it is important to take the dynamic characteristics of TBI into consideration; the synapses may act differently at different post-TBI periods. Besides, some studies conclude that combined therapies seem to exert synergistic effects and are more beneficial than single therapies [79, 80]; the role of synapse in this condition is not fully understood.

In conclusion, synapses play a significant part in the evolvement of TBI with a complicated link to various responsive mechanisms. With more acting mechanisms, synaptic protein treatments and synapsis-related treatments await to be elucidated, and further studies on this area are necessitated.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Zunjia Wen and Dong Li contributed equally to this work.

Acknowledgments

This work was supported by Suzhou Key Medical Center (Szzx201501), grants from the National Natural Science Foundation of China (nos. 81571115, 81422013, and 81471196), Scientific Department of Jiangsu Province (no. BL2014045), Suzhou Government (nos. SZS201413, SYS201608, and LCZX201601), and Jiangsu Province (no. 16KJB320008).

References

M. G. Brandel, B. R. Hirshman, B. A. McCutcheon et al., “The association between psychiatric comorbidities and outcomes for inpatients with traumatic brain injury,” Journal of Neurotrauma, vol. 34, no. 5, pp. 1005–1016, 2017.

C. An, X. Jiang, H. Pu, and Y. Gao, “Severity-dependent long-term spatial learning-memory impairment in a mouse model of traumatic brain injury,” Translational Stroke Research, vol. 7, no. 6, pp. 512–520, 2016.

P. K. Crane, L. E. Gibbons, K. Dams-O'Connor et al., “Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings,” JAMA Neurology, vol. 73, no. 9, pp. 1062–1069, 2016.

V. Jeanneret and M. Yepes, “The plasminogen activation system promotes dendritic spine recovery and improvement in neurological function after an ischemic stroke,” Translational Stroke Research, 2016.

A. Travaglia, R. Bisaz, E. Cruz, and C. M. Alberini, “Developmental changes in plasticity, synaptic, glia and connectivity protein levels in rat dorsal hippocampus,” Neurobiology of Learning and Memory, vol. 135, pp. 125–138, 2016.

K. Park, H. Heo, M. E. Han et al., “Learning-induced synaptic potentiation in implanted neural precursor cell-derived neurons,” Scientific Reports, vol. 5, p. 17796, 2015.

Q. Hu, A. Manaenko, T. Xu, Z. Guo, J. Tang, and J. H. Zhang, “Hyperbaric oxygen therapy for traumatic brain injury: bench-to-bedside,” Medical Gas Research, vol. 6, no. 2, pp. 102–110, 2016.

S. W. Carlson, H. Yan, M. Ma, Y. Li, J. Henchir, and C. E. Dixon, “Traumatic brain injury impairs soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex formation and alters synaptic vesicle distribution in the hippocampus,” Journal of Neurotrauma, vol. 33, no. 1, pp. 113–121, 2016.

N. Egawa, J. Lok, K. Washida, and K. Arai, “Mechanisms of axonal damage and repair after central nervous system injury,” Translational Stroke Research, vol. 8, no. 1, pp. 14–21, 2017.

Y. Shi, R. K. Leak, R. F. Keep, and J. Chen, “Translational stroke research on blood-brain barrier damage: challenges, perspectives, and goals,” Translational Stroke Research, vol. 7, no. 2, pp. 89–92, 2016.

L. Merlo, F. Cimino, F. F. Angileri et al., “Alteration in synaptic junction proteins following traumatic brain injury,” Journal of Neurotrauma, vol. 31, no. 16, pp. 1375–1385, 2014.

S. Herculano-Houzel, “The human brain in numbers: a linearly scaled-up primate brain,” Frontiers in Human Neuroscience, vol. 3, p. 31, 2009.

Y. P. Zhang, J. Cai, L. B. Shields, N. Liu, X. M. Xu, and C. B. Shields, “Traumatic brain injury using mouse models,” Translational Stroke Research, vol. 5, no. 4, pp. 454–471, 2014.

O. C. Logue, N. P. Cramer, X. Xu, D. P. Perl, and Z. Galdzicki, “Alterations of functional properties of hippocampal networks following repetitive closed-head injury,” Experimental Neurology, vol. 277, pp. 227–243, 2016.

T. Kawamata, Y. Katayama, D. A. Hovda, A. Yoshino, and D. P. Becker, “Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury,” Journal of Cerebral Blood Flow and Metabolism, vol. 12, no. 1, pp. 12–24, 1992.

D. Z. Liu and F. R. Sharp, “Excitatory and mitogenic signaling in cell death, blood-brain barrier breakdown, and BBB repair after intracerebral hemorrhage,” Translational Stroke Research, vol. 3, no. Supplement 1, pp. 62–69, 2012.

R. L. Hayes, L. W. Jenkins, and B. G. Lyeth, “Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids,” Journal of Neurotrauma, vol. 9, Supplement 1, pp. S173–S187, 1992.

J. Spaethling, L. Le, and D. F. Meaney, “NMDA receptor mediated phosphorylation of GluR1 subunits contributes to the appearance of calcium-permeable AMPA receptors after mechanical stretch injury,” Neurobiology of Disease, vol. 46, no. 3, pp. 646–654, 2012.

J. M. Spaethling, D. M. Klein, P. Singh, and D. F. Meaney, “Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate,” Journal of Neurotrauma, vol. 25, no. 10, pp. 1207–1216, 2008.

R. A. Nicoll and R. C. Malenka, “Expression mechanisms underlying NMDA receptor-dependent long-term potentiation,” Annals of the new York Academy of Sciences, vol. 868, no. 1, pp. 515–525, 1999.

J. F. MacDonald, M. F. Jackson, and M. A. Beazely, “Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors,” Critical Reviews in Neurobiology, vol. 18, no. 1-2, pp. 71–84, 2006.

A. Contractor and S. F. Heinemann, “Glutamate receptor trafficking in synaptic plasticity,” Science's STKE, vol. 2002, no. 156, article re14, 2002.

J. Jiang, V. Suppiramaniam, and M. W. Wooten, “Posttranslational modifications and receptor-associated proteins in AMPA receptor trafficking and synaptic plasticity,” Neurosignals, vol. 15, no. 5, pp. 266–282, 2006.

M. L. Reger, A. M. Poulos, F. Buen, C. C. Giza, D. A. Hovda, and M. S. Fanselow, “Concussive brain injury enhances fear learning and excitatory processes in the amygdala,” Biological Psychiatry, vol. 71, no. 4, pp. 335–343, 2012.

G. S. Griesbach, D. A. Hovda, D. L. Tio, and A. N. Taylor, “Heightening of the stress response during the first weeks after a mild traumatic brain injury,” Neuroscience, vol. 178, pp. 147–158, 2011.

R. K. Rowe, B. M. Rumney, H. G. May et al., “Diffuse traumatic brain injury affects chronic corticosterone function in the rat,” Endocrine Connections, vol. 5, no. 4, pp. 152–166, 2016.

J. Suzuki, G. Corfas, and M. C. Liberman, “Round-window delivery of neurotrophin 3 regenerates cochlear synapses after acoustic overexposure,” Scientific Reports, vol. 6, p. 24907, 2016.

T. A. Yacoubian and D. C. Lo, “Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth,” Nature Neuroscience, vol. 3, no. 4, pp. 342–349, 2000.

A. K. McAllister, L. C. Katz, and D. C. Lo, “Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth,” Neuron, vol. 18, no. 5, pp. 767–778, 1997.

B. Alsina, T. Vu, and S. Cohen-Cory, “Visualizing synapse formation in arborizing optic axons in vivo: dynamics and modulation by BDNF,” Nature Neuroscience, vol. 4, no. 11, pp. 1093–1101, 2001.

K. W. Kafitz, C. R. Rose, H. Thoenen, and A. Konnerth, “Neurotrophin-evoked rapid excitation through TrkB receptors,” Nature, vol. 401, no. 6756, pp. 918–921, 1999.

V. Lessmann, “Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS,” General Pharmacology, vol. 31, no. 5, pp. 667–674, 1998.

L. Kelamangalath and G. M. Smith, “Neurotrophin treatment to promote regeneration after traumatic CNS injury,” Frontiers of Biology (Beijing), vol. 8, no. 5, pp. 486–495, 2013.

K. A. Han, D. Woo, S. Kim et al., “Neurotrophin-3 regulates synapse development by modulating TrkC-PTPsigma synaptic adhesion and intracellular signaling pathways,” The Journal of Neuroscience, vol. 36, no. 17, pp. 4816–4831, 2016.

B. A. Stoica and A. I. Faden, “Cell death mechanisms and modulation in traumatic brain injury,” Neurotherapeutics, vol. 7, no. 1, pp. 3–12, 2010.

J. R. Ciallella, M. D. Ikonomovic, W. R. Paljug et al., “Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats,” Journal of Neurotrauma, vol. 19, no. 12, pp. 1555–1567, 2002.

P. P. Sordillo, L. A. Sordillo, and L. Helson, “Bifunctional role of pro-inflammatory cytokines after traumatic brain injury,” Brain Injury, vol. 30, no. 9, pp. 1043–1053, 2016.

E. C. Beattie, D. Stellwagen, W. Morishita et al., “Control of synaptic strength by glial TNFalpha,” Science, vol. 295, no. 5563, pp. 2282–2285, 2002.

J. J. O'Connor, “Targeting tumour necrosis factor-alpha in hypoxia and synaptic signalling,” Irish Journal of Medical Science, vol. 182, no. 2, pp. 157–162, 2013.

C. N. Winston, A. Noel, A. Neustadtl et al., “Dendritic spine loss and chronic white matter inflammation in a mouse model of highly repetitive head trauma,” The American Journal of Pathology, vol. 186, no. 3, pp. 552–567, 2016.

A. Chodobski, B. J. Zink, and J. Szmydynger-Chodobska, “Blood-brain barrier pathophysiology in traumatic brain injury,” Translational Stroke Research, vol. 2, no. 4, pp. 492–516, 2011.

A. Miyamoto, H. Wake, A. W. Ishikawa et al., “Microglia contact induces synapse formation in developing somatosensory cortex,” Nature Communications, vol. 7, p. 12540, 2016.

H. Lui, J. Zhang, S. R. Makinson et al., “Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation,” Cell, vol. 165, no. 4, pp. 921–935, 2016.

S. Hong, V. F. Beja-Glasser, B. M. Nfonoyim et al., “Complement and microglia mediate early synapse loss in Alzheimer mouse models,” Science, vol. 352, no. 6286, pp. 712–716, 2016.

E. Reisler and E. H. Egelman, “Actin structure and function: what we still do not understand,” The Journal of Biological Chemistry, vol. 282, no. 50, pp. 36133–36137, 2007.

M. A. Rould, Q. Wan, P. B. Joel, S. Lowey, and K. M. Trybus, “Crystal structures of expressed non-polymerizable monomeric actin in the ADP and ATP states,” The Journal of Biological Chemistry, vol. 281, no. 42, pp. 31909–31919, 2006.

J. von der Ecken, M. Muller, W. Lehman, D. J. Manstein, P. A. Penczek, and S. Raunser, “Structure of the F-actin-tropomyosin complex,” Nature, vol. 519, no. 7541, pp. 114–117, 2015.

J. Bar, O. Kobler, B. van Bommel, and M. Mikhaylova, “Periodic F-actin structures shape the neck of dendritic spines,” Scientific Reports, vol. 6, p. 37136, 2016.

I. Fernandez, D. Arac, J. Ubach et al., “Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid binding machine,” Neuron, vol. 32, no. 6, pp. 1057–1069, 2001.

R. Fernandez-Chacon, O. H. Shin, A. Konigstorfer et al., “Structure/function analysis of Ca2+ binding to the C2A domain of synaptotagmin 1,” The Journal of Neuroscience, vol. 22, no. 19, pp. 8438–8446, 2002.

M. C. Liu, V. Akle, W. Zheng et al., “Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis,” The Biochemical Journal, vol. 394, no. Part 3, pp. 715–725, 2006.

C. C. Giza, M. L. Prins, D. A. Hovda, H. R. Herschman, and J. D. Feldman, “Genes preferentially induced by depolarization after concussive brain injury: effects of age and injury severity,” Journal of Neurotrauma, vol. 19, no. 4, pp. 387–402, 2002.

S. Hilfiker, F. Benfenati, F. Doussau et al., “Structural domains involved in the regulation of transmitter release by synapsins,” The Journal of Neuroscience, vol. 25, no. 10, pp. 2658–2669, 2005.

M. A. Ansari, K. N. Roberts, and S. W. Scheff, “A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI,” Journal of Neurotrauma, vol. 25, no. 5, pp. 513–526, 2008.

S. N. Thompson, T. R. Gibson, B. M. Thompson, Y. Deng, and E. D. Hall, “Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice,” Experimental Neurology, vol. 201, no. 1, pp. 253–265, 2006.

J. Y. Ding, C. W. Kreipke, P. Schafer, S. Schafer, S. L. Speirs, and J. A. Rafols, “Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1alpha expression,” Brain Research, vol. 1268, pp. 125–134, 2009.

R. M. Perera, R. Zoncu, L. Lucast, P. De Camilli, and D. Toomre, “Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 51, pp. 19332–19337, 2006.

A. Przekwas, M. R. Somayaji, and R. K. Gupta, “Synaptic mechanisms of blast-induced brain injury,” Frontiers in Neurology, vol. 7, p. 2, 2016.

S. Dostes, S. Dubreucq, E. Ladeveze et al., “Running per se stimulates the dendritic arbor of newborn dentate granule cells in mouse hippocampus in a duration-dependent manner,” Hippocampus, vol. 26, no. 3, pp. 282–288, 2016.

F. Gomez-Pinilla, S. Vaynman, and Z. Ying, “Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition,” The European Journal of Neuroscience, vol. 28, no. 11, pp. 2278–2287, 2008.

J. M. Hall and L. M. Savage, “Exercise leads to the re-emergence of the cholinergic/nestin neuronal phenotype within the medial septum/diagonal band and subsequent rescue of both hippocampal ACh efflux and spatial behavior,” Experimental Neurology, vol. 278, pp. 62–75, 2016.

G. Manko, A. Ziolkowski, A. Mirski, and M. Kłosiński, “The effectiveness of selected tai chi exercises in a program of strategic rehabilitation aimed at improving the self-care skills of patients aroused from prolonged coma after severe TBI,” Medical Science Monitor, vol. 19, pp. 767–772, 2013.

A. A. Schmid, K. K. Miller, M. Van Puymbroeck, and N. Schalk, “Feasibility and results of a case study of yoga to improve physical functioning in people with chronic traumatic brain injury,” Disability and Rehabilitation, vol. 38, no. 9, pp. 914–920, 2016.

C. Silverthorne, S. B. Khalsa, R. Gueth, N. DeAvilla, and J. Pansini, “Respiratory, physical, and psychological benefits of breath-focused yoga for adults with severe traumatic brain injury (TBI): a brief pilot study report,” International Association of Yoga Therapists, vol. 22, no. 1, pp. 47–51, 2012.

F. da Silva Fiorin, A. P. de Oliveira Ferreira, L. R. Ribeiro et al., “The impact of previous physical training on redox signaling after traumatic brain injury in rats: a behavioral and neurochemical approach,” Journal of Neurotrauma, vol. 33, no. 14, pp. 1317–1330, 2016.

Q. Hu, A. Manaenko, Z. Guo, L. Huang, J. Tang, and J. H. Zhang, “Hyperbaric oxygen therapy for post concussion symptoms: issues may affect the results,” Medical Gas Research, vol. 5, no. 1, p. 10, 2015.

P. G. Harch, “Hyperbaric oxygen in chronic traumatic brain injury: oxygen, pressure, and gene therapy,” Medical Gas Research, vol. 5, no. 1, p. 9, 2015.

A. Kandola, J. Hendrikse, P. J. Lucassen, and M. Yücel, “Aerobic exercise as a tool to improve hippocampal plasticity and function in humans: practical implications for mental health treatment,” Frontiers in Human Neuroscience, vol. 10, p. 373, 2016.

J. Mayeux, P. Katz, S. Edwards, J. W. Middleton, and P. E. Molina, “Inhibition of endocannabinoid degradation improves outcomes from mild traumatic brain injury: a mechanistic role for synaptic hyperexcitability,” Journal of Neurotrauma, vol. 34, no. 2, pp. 436–443, 2017.

C. M. Norris, P. Sompol, K. N. Roberts, M. Ansari, and S. W. Scheff, “Pycnogenol protects CA3-CA1 synaptic function in a rat model of traumatic brain injury,” Experimental Neurology, vol. 276, pp. 5–12, 2016.

E. J. Perez, M. L. Cepero, S. U. Perez, J. T. Coyle, T. J. Sick, and D. J. Liebl, “EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain,” Neurobiology of Disease, vol. 94, pp. 73–84, 2016.

Y. Feng, Y. Cui, J. L. Gao et al., “Neuroprotective effects of resveratrol against traumatic brain injury in rats: involvement of synaptic proteins and neuronal autophagy,” Molecular Medicine Reports, vol. 13, no. 6, pp. 5248–5254, 2016.

C. R. Butler, J. A. Boychuk, and B. N. Smith, “Effects of rapamycin treatment on neurogenesis and synaptic reorganization in the dentate gyrus after controlled cortical impact injury in mice,” Frontiers in Systems Neuroscience, vol. 9, p. 163, 2015.

A. Wu, Z. Ying, and F. Gomez-Pinilla, “Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats,” Journal of Neurotrauma, vol. 21, no. 10, pp. 1457–1467, 2004.

W. Xuan, T. Agrawal, L. Huang, G. K. Gupta, and M. R. Hamblin, “Low-level laser therapy for traumatic brain injury in mice increases brain derived neurotrophic factor (BDNF) and synaptogenesis,” Journal of Biophotonics, vol. 8, no. 6, pp. 502–511, 2015.

C. L. Liu, K. Zhang, and G. Chen, “Hydrogen therapy: from mechanism to cerebral diseases,” Medical Gas Research, vol. 6, no. 1, pp. 48–54, 2016.

Q. Hu, A. Manaenko, N. Matei et al., “Hyperbaric oxygen preconditioning: a reliable option for neuroprotection,” Medical Gas Research, vol. 6, no. 1, pp. 20–32, 2016.

M. C. Laplaca and G. R. Prado, “Neural mechanobiology and neuronal vulnerability to traumatic loading,” Journal of Biomechanics, vol. 43, no. 1, pp. 71–78, 2010.

A. E. Kline, J. B. Leary, H. L. Radabaugh, J. P. Cheng, and C. O. Bondi, “Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: is more better?” Progress in Neurobiology, vol. 142, pp. 45–67, 2016.

S. Margulies, G. Anderson, F. Atif et al., “Combination therapies for traumatic brain injury: retrospective considerations,” Journal of Neurotrauma, vol. 33, no. 1, pp. 101–112, 2016.